Income Statement (Annual)

CVSI / CV Sciences, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Adminstrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000 except per share units.

2011 2012 2013 2014 2015 2016
Revenues - 0 2,154 10,191 11,529 11,061
Cost Of Revenue - 0 880 4,387 4,421 4,063
Gross Profit - 0 1,274 5,804 7,108 6,998
Operating Expenses
  General And Administrative Expense 88 43 2,366 13,358 17,755 13,130
  Research And Development Expense - 0 524 999 1,320 1,159
  Operating Expenses 88 43 2,891 14,357 19,075 14,289
  Operating Income Loss - -43 -1,617 -8,553 -11,210 -13,074
  Other Expenses
    Interest Income Operating - - 0 31 18 28
    Interest Expense -2 3 372 615 969 1,087
    Gain Loss On Sale Of Investments - 0 -311 -39 0 -
    Gain Loss On Sale Of Equity Investments - - 0 7,899 0 -
    Other Expenses - 3 683 35 73 9
    Profit Loss - -46 -2,300 -1,312 -12,233 -
    Other Nonoperating Income Expense - - -683 7,241 -1,024 -1,068
    Income Tax Expense Benefit - 0 0 0 0 0
    Net Income Loss -90 -46 -2,300 -1,312 -12,233 -14,141
    Earnings Per Share Basic And Diluted -0 -0 -0 - -0 -0
    Weighted Average Number Of Share Outstanding Basic And Diluted - 7,000 9,879 - 35,142 52,661
    Weighted Average Number Of Shares Outstanding Basic 6,971 7,000 9,879 31,581 35,142 -
    Earnings Per Share Basic - - -0 -0 -0 -
Litigation Settlement Amount - - - 0 757 0
Gain On Collection Of Related Party Notes Receivable - - - - 0 379
Derivative Gain Loss On Derivative Net - - - - 0 147
Inventory Write Down - - - - 0 3,562
Goodwill And Intangible Asset Impairment - - 0 0 0 2,747
Operating Costs And Expenses - - - - 17,941 20,071
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest - - - - -12,233 -14,141

Related News Stories

Top-Performing Marijuana Stocks Of December

2017-12-28 seekingalpha
December has seen the culmination of at least 2 distinct catalysts propel several leading marijuana stocks much higher before the end of the year. (48-1)

CV Sciences, Inc. 2017 Q3 - Results - Earnings Call Slides

2017-11-10 seekingalpha
The following slide deck was published by CV Sciences, Inc. in conjunction with their 2017 Q3 earnings call. (3-1)

CV Sciences' (CVSI) Management on Q3 2017 Results - Earnings Call Transcript

2017-11-09 seekingalpha
Greetings and welcome to CV Sciences’ 2017 Third Quarter Conference Call. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] Remind you that this conference is being recorded. (9-0)

CV Sciences Takes Aim at Smokeless Tobacco Addiction with CBD-Based Therapy

2017-10-17 accesswire
SANTA MONICA, CA / ACCESSWIRE / October 17, 2017 / According to the Centers for Disease Control and Prevention, tobacco use causes almost six million deaths annually, with that number expected to climb to eight million by 2030 based on current trends. In the U.S. alone, about one in five deaths, or approximately 1,300 deaths every day, are the result of cigarette smoking, making it a leading cause of preventable death. (3-1)

CUSIP: 126654102